FABFusion AntibodiesFAB info
$0.04info-8.33%24h
Global rank35665
Market cap$2.59M
Change 7d1.54%
YTD Performance-22.35%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Fusion Antibodies (FAB) Stock Overview

    Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, and diagnostic companies. The company has a collaboration partnership with Celonic AG. The company was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.

    FAB Stock Information

    Symbol
    FAB
    Address
    1 Springbank RoadBelfast, BT17 0QLUnited Kingdom
    Founded
    -
    Trading hours
    8:00 AM - 4:30 PM GMT
    Website
    https://www.fusionantibodies.com
    Country
    🇬🇧 United Kingdom
    Phone Number
    44 28 9043 2800

    Fusion Antibodies (FAB) Price Chart

    -
    Value:-

    Fusion Antibodies Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.04356033105851605
    N/A
    Market Cap
    $2.59M
    N/A
    Shares Outstanding
    59.45M
    N/A
    Employees
    48.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org